917 related articles for article (PubMed ID: 31821122)
1.
Sibille L; Seifert R; Avramovic N; Vehren T; Spottiswoode B; Zuehlsdorff S; Schäfers M
Radiology; 2020 Feb; 294(2):445-452. PubMed ID: 31821122
[TBL] [Abstract][Full Text] [Related]
2. Just another "Clever Hans"? Neural networks and FDG PET-CT to predict the outcome of patients with breast cancer.
Weber M; Kersting D; Umutlu L; Schäfers M; Rischpler C; Fendler WP; Buvat I; Herrmann K; Seifert R
Eur J Nucl Med Mol Imaging; 2021 Sep; 48(10):3141-3150. PubMed ID: 33674891
[TBL] [Abstract][Full Text] [Related]
3. Deep convolutional neural network for differentiating between sarcoidosis and lymphoma based on [
Aoki H; Miyazaki Y; Anzai T; Yokoyama K; Tsuchiya J; Shirai T; Shibata S; Sakakibara R; Mitsumura T; Honda T; Furusawa H; Okamoto T; Tateishi T; Tamaoka M; Yamamoto M; Takahashi K; Tateishi U; Yamaguchi T
Eur Radiol; 2024 Jan; 34(1):374-383. PubMed ID: 37535157
[TBL] [Abstract][Full Text] [Related]
4. The OCDA-Net: a 3D convolutional neural network-based system for classification and staging of ovarian cancer patients using [
Sadeghi MH; Sina S; Alavi M; Giammarile F
Ann Nucl Med; 2023 Dec; 37(12):645-654. PubMed ID: 37768493
[TBL] [Abstract][Full Text] [Related]
5. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
6. Deep learning for [
Häggström I; Leithner D; Alvén J; Campanella G; Abusamra M; Zhang H; Chhabra S; Beer L; Haug A; Salles G; Raderer M; Staber PB; Becker A; Hricak H; Fuchs TJ; Schöder H; Mayerhoefer ME
Lancet Digit Health; 2024 Feb; 6(2):e114-e125. PubMed ID: 38135556
[TBL] [Abstract][Full Text] [Related]
7. Convolutional Neural Networks in Predicting Nodal and Distant Metastatic Potential of Newly Diagnosed Non-Small Cell Lung Cancer on FDG PET Images.
Tau N; Stundzia A; Yasufuku K; Hussey D; Metser U
AJR Am J Roentgenol; 2020 Jul; 215(1):192-197. PubMed ID: 32348182
[No Abstract] [Full Text] [Related]
8. The role of 18F-FDG PET/CT in staging and restaging primary bone lymphoma.
Liu Y
Nucl Med Commun; 2017 Apr; 38(4):319-324. PubMed ID: 28225435
[TBL] [Abstract][Full Text] [Related]
9. Application of a neural network to improve nodal staging accuracy with 18F-FDG PET in non-small cell lung cancer.
Vesselle H; Turcotte E; Wiens L; Haynor D
J Nucl Med; 2003 Dec; 44(12):1918-26. PubMed ID: 14660717
[TBL] [Abstract][Full Text] [Related]
10. Convolutional Neural Networks Promising in Lung Cancer T-Parameter Assessment on Baseline FDG-PET/CT.
Kirienko M; Sollini M; Silvestri G; Mognetti S; Voulaz E; Antunovic L; Rossi A; Antiga L; Chiti A
Contrast Media Mol Imaging; 2018; 2018():1382309. PubMed ID: 30510492
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic value of fluorine 18 fluorodeoxyglucose positron emission tomography/computed tomography for the detection of metastases in non-small-cell lung cancer patients.
Wu Y; Li P; Zhang H; Shi Y; Wu H; Zhang J; Qian Y; Li C; Yang J
Int J Cancer; 2013 Jan; 132(2):E37-47. PubMed ID: 22890912
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary Lymphangitic Carcinomatosis: Diagnostic Performance of High-Resolution CT and
Jreige M; Dunet V; Letovanec I; Prior JO; Meuli RA; Beigelman-Aubry C; Schaefer N
J Nucl Med; 2020 Jan; 61(1):26-32. PubMed ID: 31227574
[TBL] [Abstract][Full Text] [Related]
13. Automatic detection and classification of regions of FDG uptake in whole-body PET-CT lymphoma studies.
Bi L; Kim J; Kumar A; Wen L; Feng D; Fulham M
Comput Med Imaging Graph; 2017 Sep; 60():3-10. PubMed ID: 27955798
[TBL] [Abstract][Full Text] [Related]
14. Primary Central Nervous System Lymphoma: Diagnostic Yield of Whole-Body CT and FDG PET/CT for Initial Systemic Imaging.
Suh CH; Kim HS; Park JE; Jung SC; Choi CG; Kim SJ
Radiology; 2019 Aug; 292(2):440-446. PubMed ID: 31237497
[TBL] [Abstract][Full Text] [Related]
15. Added value of pretreatment (18)F-FDG PET/CT for staging of advanced gastric cancer: Comparison with contrast-enhanced MDCT.
Kawanaka Y; Kitajima K; Fukushima K; Mouri M; Doi H; Oshima T; Niwa H; Kaibe N; Sasako M; Tomita T; Miwa H; Hirota S
Eur J Radiol; 2016 May; 85(5):989-95. PubMed ID: 27130061
[TBL] [Abstract][Full Text] [Related]
16. Comparison of
Wang L; Tang G; Hu K; Liu X; Zhou W; Li H; Huang S; Han Y; Chen L; Zhong J; Wu H
Radiology; 2022 Apr; 303(1):191-199. PubMed ID: 34981976
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic accuracy of 18F-2-deoxy-fluoro-D-glucose positron emission tomography for pN1 lymph nodes in patients with lung cancer.
Nakagawa M; Hara M; Sakurai K; Ozawa Y; Mizuno A; Tamaki T; Nishio M; Shibamoto Y
Acta Radiol; 2009 Jul; 50(6):638-44. PubMed ID: 19492198
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary mucosa-associated lymphoid tissue lymphoma:
Albano D; Borghesi A; Bosio G; Bertoli M; Maroldi R; Giubbini R; Bertagna F
Br J Radiol; 2017 Nov; 90(1079):20170311. PubMed ID: 28830222
[TBL] [Abstract][Full Text] [Related]
19. Artificial intelligence for detecting small FDG-positive lung nodules in digital PET/CT: impact of image reconstructions on diagnostic performance.
Schwyzer M; Martini K; Benz DC; Burger IA; Ferraro DA; Kudura K; Treyer V; von Schulthess GK; Kaufmann PA; Huellner MW; Messerli M
Eur Radiol; 2020 Apr; 30(4):2031-2040. PubMed ID: 31822970
[TBL] [Abstract][Full Text] [Related]
20. Regional nodal staging with 18F-FDG PET-CT in non-small cell lung cancer: Additional diagnostic value of CT attenuation and dual-time-point imaging.
Li M; Wu N; Liu Y; Zheng R; Liang Y; Zhang W; Zhao P
Eur J Radiol; 2012 Aug; 81(8):1886-90. PubMed ID: 21511421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]